Case SeriesFree Access

Department of Oral & Maxillofacial Medicine, DDs, MSc, Assistant Professor, Alborz University of Medical Sciences, Tehran, Alborz, Iran

*Author for correspondence: Tel.: +989 126 400 743;

E-mail Address: ghasemzade@gmail.com

https://orcid.org/0000-0001-7846-5439

Department of Oral & Maxillofacial Medicine, DDs, MSc, Assistant professor, School of Dentistry, Kashan University of Medical Science, Isfahan, Iran

Search for more papers by this author

Fatemeh Atoof

Biostatistics, Assistant Professor, Kashan University of Medical Sciences, Kashan, Iran

Search for more papers by this author

Reza Mottaghi

Department of Oral & Maxillofacial Surgery, DDs, student Dentistry, Student Research Center, School of Dentistry, Kashan University of Medical Sciences, Isfahan, Iran

Search for more papers by this author

Published Online:6 Apr 2021https://doi.org/10.2217/fvl-2020-0334

View article

Abstract

Introduction: Dry mouth has been reported as a symptom of COVID-19. In this study, xerostomia (dry mouth) was reported in patients with COVID-19. Materials & methods: Dry mouth was assessed in hospitalized patients with COVID-19 daily until all of the dry mouth symptoms resolved. Results: Dry mouth appeared in 60% of cases 3–4 days before as prodromal symptom and in others, simultaneously or 1–2 days after the onset of other symptoms. In most cases, with starting the treatment, dry mouth gradually disappeared. Conclusion: Xerostomia in COVID-19 could occur before the common symptoms. Therefore, it could be hypothesized that it could be used for early diagnosis, quarantine and treatment. As a result, disease transmission might be prevented and the best treatment outcomes could be achieved.

Keywords:

References

1. Tanasiewicz M, Hildebrandt T, Obersztyn I. Xerostomia of various etiologies: a review of the literature. Adv. Clin. Exp. Med. 25(1), 199–206 (2016).
MedlineGoogle Scholar
2. Glick M. Burket's Oral Medicine. PMPH, Buffalo, NY, USA (2015).
Google Scholar
3. Bagley AF, Ye R, Garden AS et al. Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother. Oncol. 142, 133–139 (2020).
MedlineGoogle Scholar
4. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. (2020). https://covid19.who.int/
Google Scholar
5. Freni F, Meduri A, Gazia F et al. Symptomatology in head and neck district in coronavirus disease (COVID-19): a possible neuroinvasive action of SARS-CoV-2. Am. J. Otolaryngol. 41(5), 102612 (2020).
Medline CASGoogle Scholar
6. Fantozzi PJ, Pampena E, Di Vanna D et al. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19. Am. J. Otolaryngol. 41(6), 102721 (2020).
Medline CASGoogle Scholar
7. Mollica V, Rizzo A, Massari F. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Future Oncol. (London, England) 16(27), 2029–2033 (2020).
CASGoogle Scholar
8. Song J, Li Y, Huang X et al. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2. J. Med. Virol. 92(11), 2556–2566 (2020).
Medline CASGoogle Scholar
9. Liu L, Wei Q, Alvarez X et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J. Virol. 85(8), 4025–4030 (2011).
Medline CASGoogle Scholar
10. Da Silva Pedrosa M, Sipert CR, Nogueira FN. Altered taste in patients with COVID-19: the potential role of salivary glands. Oral Dis. 27(S3), 798–800 (2020).
MedlineGoogle Scholar
11. Lozada-Nur F, Chainani-Wu N, Fortuna G, Sroussi H. Dysgeusia in COVID-19: possible mechanisms and implications. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 130(3), 344–346 (2020).
MedlineGoogle Scholar
12. Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis. 27(S3), 703–706 (2020).
MedlineGoogle Scholar
13. Pedrosa MDS, Sipert CR, Nogueira FN. Salivary glands, saliva and oral findings in COVID-19 infection. Pesqui. Bras. Odontopediatria Clín. Integr. 20(supp1), e0104 (2020).
CASGoogle Scholar
14. Lechien JR, Chetrit A, Chekkoury-Idrissi Y et al. Parotitis-like symptoms associated with COVID-19, France, March–April 2020. Emerg. Infect. Dis. 26(9), 2270 (2020).
CASGoogle Scholar
15. Biadsee A, Biadsee A, Kassem F, Dagan O, Masarwa S, Ormianer Z. Olfactory and oral manifestations of COVID-19: sex-related symptoms – a potential pathway to early diagnosis. Otolaryngol. Head Neck Surg. 163(4), 722–728 (2020).
MedlineGoogle Scholar

Vol. 16, No. 5

Metrics

Downloaded 415,089 times

History

Received 2 October 2020

Accepted 22 March 2021

Published online 6 April 2021

Published in print May 2021

Information

Keywords

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

English Edit Institute editing services were utilized in the production of this manuscript.

Ethical conduct of research

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.

PDF download

Xerostomia (dry mouth) in patients with COVID-19: a case series

Abstract

References